Some stock data isn't available right now.
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)
Underlying price
$493.62-1.16% today
Stock stats
- Market cap
- $11.5B
- Previous close
- $499.40
- Open
- $501.89
- Day's range
- $491.25 – $505.00
- 52-week range
- $393.60 – $615.00
- Volume
- 245K
- Avg volume
- 223K
- P/E ratio
- -
About Madrigal Pharmaceuticals, Inc. Common Stock
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
- Ticker
- MDGL
- Asset class
- Equity
- Tokenized by
- 0 issuers
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Employees
- 915
- Website
- madrigalpharma.com